Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy.
about
Long-term results of rituximab-intravenous immunoglobulin combination therapy in patients with epidermolysis bullosa acquisita resistant to conventional therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Long-term results of rituximab ...... stant to conventional therapy.
@en
Long-term results of rituximab ...... stant to conventional therapy.
@nl
type
label
Long-term results of rituximab ...... stant to conventional therapy.
@en
Long-term results of rituximab ...... stant to conventional therapy.
@nl
prefLabel
Long-term results of rituximab ...... stant to conventional therapy.
@en
Long-term results of rituximab ...... stant to conventional therapy.
@nl
P2093
P2860
P50
P1476
Long-term results of rituximab ...... stant to conventional therapy.
@en
P2093
Ayse Oktem
Cengizhan Erdem
Hatice Sanli
Nihal Kundakci
Seher Bostancı
P2860
P356
10.1080/09546634.2016.1179711
P577
2016-05-10T00:00:00Z